Type of lymphoma treatment impacts degree of harm to sperm

July 28, 2014
Type of lymphoma treatment impacts degree of harm to sperm
Lymphoma treatment has damaging effects on spermatogenesis but, in most patients, sperm production recovers within two years post-treatment, according to a study published online July 17 in Fertility and Sterility.

(HealthDay)—Lymphoma treatment has damaging effects on spermatogenesis but, in most patients, sperm production recovers within two years post-treatment, according to a study published online July 17 in Fertility and Sterility.

Louis Bujan, M.D., Ph.D., from Université de Toulouse in France, and colleagues compared sperm characteristics in 75 Hodgkin's lymphoma and non-Hodgkin's (before treatment and after three, six, 12, and 24 months) and a of 257 fertile men.

The researchers found that patients with no identified risk factor already had altered sperm characteristics before . After treatment, , total sperm count, motility, and vitality decreased, with lowest seen values at three and six months. Mean sperm count recovered to pretreatment values after doxorubicin, bleomycin, vinblastine, darcarbacine (ABVD) or ABVD + radiotherapy at 12 months after treatment, but not after doxorubicin, cyclophosphamide, vincristine, prednisone or mechlorethamine, oncovin, procarbazine, prednisone chemotherapies. At 24 months, 7 percent of patients remained azoospermic. Only pretreatment total sperm count was related to recovery in multivariate analyses, including diagnosis and treatment protocol.

"Lymphoma patients had altered sperm DNA and chromatin before treatment. Lymphoma treatment had damaging effects on spermatogenesis," the authors write. "These data on both the recovery period according to treatment modalities and the pre- and post-treatment chromatin status of sperm are useful tools for counseling patients wishing to conceive."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

HIV status doesn't influence Hodgkin's lymphoma outcome

October 11, 2012

(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, and dacarbazine ...

Frozen testicle tissue yields healthy baby mice

July 1, 2014

Sperm grown from the frozen testicle tissue of newborn mice has been used to produce healthy offspring, in a hopeful development for men left infertile by childhood cancer treatment, researchers said Tuesday.

Recommended for you

Study reveals new insight into DNA repair

August 3, 2015

DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy. New information published this week reveals more about why this occurs and how these breaks ...

Strange circular DNA may offer new way to detect cancers

July 30, 2015

Strange rings of DNA that exist outside chromosomes are distinct to the cell types that mistakenly produced them, researchers have discovered. The finding raises the tantalizing possibility that the rings could be used as ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.